amiodarone has been researched along with Corneal Dystrophies in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garmizo, G | 1 |
| Iwaszkiewicz-Bilikiewiczowa, B | 1 |
| Janukowiczowa, H | 1 |
2 other studies available for amiodarone and Corneal Dystrophies
| Article | Year |
|---|---|
Ocular manifestations of Fabry's disease.
Topics: Amiodarone; Corneal Dystrophies, Hereditary; Diagnosis, Differential; Fabry Disease; Humans | 1987 |
[Development of corneal changes in patients treated with cordarone (amiodarone)].
Topics: Aged; Amiodarone; Benzofurans; Cornea; Corneal Dystrophies, Hereditary; Female; Humans; Male; Middle | 1985 |